$3.94
-0.29-6.86%
Last update: Nov 5, 5:16 PM
CollPlant Biotechnologies Ltd
CLGNNASDAQ
The average analyst price target for CollPlant Biotechnologies is $125, 3009.5% above the current price. Of 3 analysts, 2 rate it Buy and 1 Hold. Targets range from $110 to $140. The latest change came on Feb 6, 2026, when D. Boral Capital downgraded CollPlant Biotechnologies from Buy to Hold.
Price Target Range — 8 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
